Latest multiple sclerosis News | Page 5

WHO endorses landmark public health decisions on Essential Medicines for Multiple Sclerosis
Eight Curtin health and medical research projects awarded funding
What is medical cannabis?
Autoimmunity art: Making science accessible for blind and low-vision audiences
First genetic marker discovered for MS severity
New clues in understanding faster disease progression in multiple sclerosis
New change facility in Busselton to support locals and visitors with disability
New study to help Aussie farmers curb chronic pain
Top Griffith scientists head to Canberra to make case for thousands with ME/CFS
New study reduces risks associated with MS medication
Native tobacco plants reborn as ‘biofactories’ for medicines
Tackling the rise of autoimmune diseases with genetically modified cell therapies
Monash Expert: Spotlight on multiple sclerosis as numbers climb
Shining light on ‘lesser known’ disability
The budget includes $7.3 million to get more young people out of aged care homes. Is it enough?
How old are your internal organs?
A novel biomarker and potential improved therapy for multiple sclerosis and related neurodegenerative disorders
Bacterial toxin may trigger multiple sclerosis onset and relapse
Karen’s inspiring journey to become fearless
Funding flags hope for MS treatment and prevention
Study to explore link between diet and multiple sclerosis in children
Targeting proteins may lead to MS treatment breakthrough
Study finds link between blood components and brain disorders
Mode Medical Pty Ltd and executive officer fined almost $160,000 for alleged unlawful advertising of intravenous infusion products
Obesity linked to macular degeneration
Immune cells help protect brain health and cognition
2022 Betty McGrath Seeding Grant Winners
Netflix psychiatrist Phil Stutz says 85% of early therapy gains are down to lifestyle changes
Celebrating people with disability within Queensland Police Service
Chris Hemsworth’s Alzheimer’s gene doesn’t guarantee he’ll develop dementia
New precinct and homes for Lidcombe
Big data used to identify existing drugs that could be repurposed for broader medical applications
Changing treatment can help MS patients: study
NSW police remind motorists of road closures ahead of 40th MS Sydney to Gong charity bike ride
Ultomiris showed zero relapses in adults with neuromyelitis optica spectrum disorder with median treatment duration of
Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022
Major ANU funding win to boost health for all Australians
Penrith celebrates 30 years of Council’s Access Committee
‘They treat you like a person, they ask you what you want’: what NDIS participants value in support workers
Treatment offers new hope for lupus – and maybe for other autoimmune diseases too
Long COVID inquiry encouraging, but more work needed on how to treat patients
Cells help immune system tolerate friendly gut bacteria
Covid oral treatments
What allegations of Alzheimer’s research fraud mean for patients
PBS Listings will help people with spinal muscular atrophy, schizophrenia and multiple sclerosis
Multiple sclerosis diagnosis hasn’t stopped footballer kicking goals
Finding triggers of inflammation
NeuroScientific Biopharmaceuticals seeks approval for phase 1 trial